Dr. Akvile Ignotaite

Dr. Akvile Ignotaite is the founder and CEO of System Akvile, a skin-tech startup that focuses on providing personalized skincare solutions, particularly for people with acne-prone skin.12 She is a data scientist with a Ph.D. in Data Science and Sustainability from Leuphana Universität Lüneburg, where she graduated magna cum laude.1

Professional Background

Dr. Ignotaite founded System Akvile in August 2019, with the goal of unlocking the power of health data through hypergrowth, proprietary data, and AI/ML technologies.1 Prior to this, she gained experience in various fields:

• M&A at L'Etoile Properties (2016-2017)
• Management at Latham & Watkins (2012-2015)
• Corporate Consultant at Enterprise Lithuania (2010-2011)

Education

Dr. Ignotaite has a diverse educational background:

• Doctor in Data Science & Sustainability from Leuphana Universität Lüneburg (2012-2016)
• MBA and M.Sc. from Universität Hamburg (2009-2011)
• Economics from Vilnius University
• Entrepreneurship program at Harvard University (2017)
• Emerging Economies program at the University of Oxford (2016)

System Akvile

System Akvile is an all-in-one app for skin health that launched in 2021.2 The app uses a comprehensive approach to skincare, combining data analytics, clinical science, and advanced technology to help users understand and manage their skin health.3 It identifies triggers, tracks progress, and educates users with scientific facts about their skin condition.2

In collaboration with Haut.AI, a leading AI company specializing in skincare and longevity, System Akvile has implemented AI algorithms that can assess up to 150 visual wellness biomarkers of the skin.2 This partnership aims to provide users with personalized skin analysis and actionable insights for improved quality of life and well-being.3

Dr. Ignotaite's vision for System Akvile is to change the approach to skin health by addressing the fragmented market and meeting both short-term and long-term needs of people with skin conditions.2 The app has gained significant user numbers and confidence levels since its launch, with plans to expand to other skin conditions beyond acne.2